ReviewTherapeutic advances in neurological disorders2023

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials.

Antonios Bayas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.